CMML Risk Stratification Gene Panel near me in Nagpur

Chronic Myelomonocytic Leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm, which means it has characteristics of both myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPN). Risk stratification in CMML is important for guiding treatment decisions and understanding the prognosis of the disease. Next-generation sequencing (NGS) is a powerful tool in the risk stratification of CMML because it allows for the detection of genetic mutations associated with the disease.